Specify a stock or a cryptocurrency in the search bar to get a summary
Rxsight Inc
RXSTRxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Address: 100 Columbia, Aliso Viejo, CA, United States, 92656
Analytics
WallStreet Target Price
64.86 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures RXST
Dividend Analytics RXST
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RXST
Stock Valuation RXST
Financials RXST
Results | 2019 | Dynamics |